159 results about "Microbial disease" patented technology

The present invention discloses a selective and a non-selective method and means of treating microbial diseases in local infections. The novel method comprising the step of emitting a beam of a blue light towards the tissue to be treated, wherein the beam is having a wavelength from 400 to 550 nanometers and further wherein the temperature of said tissue is not exceeding about 42° C. along the procedure or immediately after it so that a selective phototoxic effect is exerted. A cost effective device for selectively or non-selectively exerting phototoxic effect by emitting a beam of blue light towards a tissue to be treated is also provided useful, especially for dental application.

The invention concerns the application of the fungal organism Pythium oligandrum as a strong mycoparasite in connection with the applicable inorganic or organic carrier of the efficient agens as a preparation for additional fertilization and for protection of plants against the originators of microbial diseases and as a preparation for the elimination of post-harvest losses and losses during storage of commodities coming from plant or animal production, including the preparation for the liquidation of wood-destroying fungi. The application of the preparation for the protection of plants against the originators of microbial diseases can also be performed in the form of aerial spraying.

A method for studying scaffold-based tissue engineering approaches in combination with the use of progenitor or stem cells to generate new lung tissue in an in vitro system. The engineered tissue system of this invention is used to monitor lung and immune system exposure of pathogen and / or toxins. The method involves growing engineered lung / immune tissue from progenitor cells in a bioreactor and then exposing the engineered lung / immune tissue to a pathogen and / or toxin. Once exposed, response of the engineered tissue is monitored to determine the effects of exposure to the immune component of the tissue and to lung component of the tissue. This invention also involves development of mixed engineered tissues including a first fully functional engineered tissue such as lung tissue and a second fully functional engineered tissued such as immune tissue from a single animal donor. The mixed systems can include more than two engineered tissues.

A method of selectively treating microbiological pathogens which are implicated in the advancement of periodontitis is disclosed. Preferably, the microbiological pathogens are phorphyromonas gingivalis (Pg) and prevotella intermedia (Pi) which are known to colonize in dental plaque, cementum, gingival sulcus epithelium and surrounding periodontal tissues. The microbiological pathogens can also include pigmented fungi such as Histoplasma and Aspirgillus Niger. The microbiological pathogens are selectively irradiated with high-energy antiseptic laser pulses which are strongly absorbed by the microbiological pathogens and which are substantially transparent to the periodontal tissues. Preferably, high-energy antiseptic laser pulses eradicate a portion of the microbiological pathogens within the periodontal tissues without requiring aggressive debridement procedures.

The invention discloses a novel compound microorganism living bacteria agent. The agent comprises probiotics such as pediococcus, saccharomyces, bacillus and the like, wherein the total bacterial quantity is above 107 colony-forming units (cfu) / gram. The invention further discloses a method for preparing the novel compound microorganism living bacteria agent and applications of the novel compound microorganism living bacteria agent in preparation of organic sewage purification additives, deodorization fly dispelling agents, degreasing agents, pipeline blockage removing agents, feed additives and microorganism disease prevention agents. The novel compound microorganism living bacteria agent has the comprehensive effects of high removal rates to ammonia nitrogen, total nitrogen and total phosphorus, small sludge residues, energy saving, environmental friendliness and the like and the characteristics of convenience in use, safety and quickness in function, no secondary pollution, benefits to ecological protection, low treatment cost, good comprehensive profit and the like.

The present invention relates in part to a composition comprising a compound of Formula I or Formula II and at least one other antimicrobial agent. The invention also relates in part to a pharmaceutical composition comprising the composition of claim 1 and a pharmaceutically acceptable carrier or excipient. The invention further relates in part to a method of treating a subject with a microbial illness comprising administering to a subject in need thereof the aforementioned pharmaceutical composition. The invention further relates in part to a method of disinfecting a surface comprising administering to the surface the aforementioned a composition. The invention also relates in part to a coating comprising the aforementioned composition.

The invention relates to a composite nano fiber filtration material with photocatalysis / anti-bacterial functions and a preparation method of the filtration material. The filtration material comprises a supporting layer and a nano fiber filtration layer which adheres to the surface of the supporting layer, the nano fiber layer is uniformly filled with an photocatalyst and an antibacterial agent, and the preparation method comprises the following steps: 1, preparing a spinning liquid: dispersing a certain amount of the photocatalyst and the antibacterial agent into a solution uniformly to form a dispersion liquid, performing ultrasonic treatment, and adding a high polymer to form a stable and uniform electrostatic spinning solution; 2, performing electrostatic spinning: setting up electrostatic spinning parameters, and performing stretching on the spinning polymer solution at solid metal wire tips for wire production by utilizing an assembled needle head; and 3, performing slight dissolving treatment on the surface of the composite nano fiber filtration material by adopting solvent vapour recovery at a certain releasing speed to obtain the final composite nano fiber filtration material with the photocatalysis / the anti-bacterial functions. The composite nano fiber filtration material effectively solves a problem that the liquid outlet end of a current needle head / spray nozzle used for the electrostatic spinning is easy to block, can be directly used for decomposition of organic pollutants, inactivation of microorganism pathogenes and the like under visible light, and has excellent filtration performance at the same time.

The present invention relates to the use of the cyclic dinucleotide c-di-GMP and cyclic dinucleotide analogues thereof in a method for attenuating virulence of a microbial pathogen or for inhibiting or reducing colonization by a microbial pathogen. This method further inhibits microbial biofilm formation and is capable of treating bacterial infections. The microbial colonization or biofilm formation inhibited or reduced may be on the skin or on nasal or mucosal surface. The microbial colonization or biofilm formation inhibited can also be on the surfaces of medical devices, especially those in close contact with the patient, as well on the surfaces of industrial and construction material where microbial colonization and biofilm formation is of concern.

The present invention discloses a selective and a non-selective method and means of treating microbial diseases in local infections. The novel method comprising the step of emitting a beam of a blue light towards the tissue to be treated, wherein the beam is having a wavelength from 400 to 550 nanometers and further wherein the temperature of said tissue is not exceeding about 42° C. along the procedure or immediately after it so that a selective phototoxic effect is exerted. A cost effective device for selectively or non-selectively exerting phototoxic effect by emitting a beam of blue light towards a tissue to be treated is also provided useful, especially for dental application.

Compositions and methods for preparing stabilized CSA compositions having reduced agglomeration and increased stability. The compositions have increased efficacy in killing microbes and reduced cytotoxicity to mammals. The compositions include a liquid carrier, micelles formed from an amphiphilic material, and CSA molecules encapsulated by the micelles. The CSA compositions can be formed by blending together a solvent or liquid carrier, a plurality of CSA molecules, and a micelle-forming agent and causing or allowing the micelle-forming agent to form micelles encapsulating at least a portion of the CSA molecules so that no more than 25% of the CSA molecules form agglomerates larger than 1 μm in size. The CSA compositions can be used to treat mammals, such as mammals suffering from microbial diseases or infections.

Non-hemolytic cytolytic agents selected from peptides, complexes of bundled peptides, mixtures of peptides or random peptide copolymers have a selective cytolytic activity manifested in that they have a cytolytic activity on pathogenic cells, being cells which are non-naturally occurring within the body consisting of microbial pathogenic organisms and malignant cells; and are non-hemolytic, having no cytolytic effect on red blood cells. The peptides may be cyclic derivatives of natural peptides such as pardaxin and mellitin and fragments thereof in which L-amino acid residues are replaced by corresponding D-amino acid residues, or are diastereomers of linear peptides composed of varying ratios of at least one positively charged amino acid and at least one hydrophobic amino acid, and in which at least one of the amino acid residues is a D-amino acid. Pharmaceutical compositions comprising the non-hemolytic cytolytic agents can be used for the treatment of several diseases caused by pathogens including antibacterial, fungal, viral, mycoplasma and protozoan infections and for the treatment of cancer.

Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection. In particular, methods for using Abl-family tyrosine kinase inhibitors to treat pathogenic infection are provided. Infections to be treated according to the present invention include, particularly, those caused by microbial pathogens such as bacteria and viruses.

The present invention relates to a fusion protein capable of activating the complement system, the fusion protein comprising a first polypeptide sequence derived from a lectin-complement pathway activating protein or a functional homologue thereof; and a second polypeptide sequence derived from a collectin or a functional homologue thereof; wherein said complement activating protein is not a collectin. A preferred fusion protein comprises amino acids of the L-ficolin sequence of FIG. 1 and amino acids of the MBL sequence shown in FIG. 2. The fusion protein is suitable for use in treatment consisting of creation, reconstitution, enhancing and / or stimulating the opsonic and / or bactericidal activity of the complement system, i.e. enhancing the ability of the immune defence to recognise and kill microbial pathogens, and accordingly, the invention relates to a medicament comprising the fusion protein, methods for producing said fusion protein and methods for treating diseases, in particular infections.

A method for in situ detection of viable pathogenic bacteria in a selective medium by measuring cathodic peak current of oxygen on cyclic voltammograms during bacterial proliferation with an electrochemical voltammetric analyzer. The rapid oxygen consumption at a time during the growth of bacteria resulted in a sharp decline of the cathodic peak current curves. The detection times (threshold values) obtained from the cathodic peak current curve were inversely related to the concentrations of the pathogenic bacteria in the medium. This method for detection of pathogenic bacteria is more sensitive than nucleic acid-based polymerase chain reaction (PCR) methods and any of antibody-based methods such as enzyme-linked immunosorbent assay (ELISA) technology, electrochemical immunoassays, immunosensors, and it has a sensitivity similar to conventional culture methods and impedimetric methods but is more rapid than both of them. A calibration curve was obtained by plotting initial cell concentrations (CFU / ml) determined by conventional plate counting, as a function of the detection time.

The present invention provides feed additive composition comprising fermented yeast, sodium metabisulfite, and optionally thiamin. When a normal or basal feed is supplemented with the feed additive, improved growth, improved health, improved intestinal health, and a reduction of microbial pathogens is seen in non-human animals as compared to a control group.

The invention discloses an oxygen enriching and sterilizing device and an oxygen enriching and sterilizing method for soilless culture nutrient solution. The method includes dissolving air or oxygen into the nutrient solution by the aid of a micro-nano bubble generation technology to form micro-nano bubble oxygen-enriched water so as to enrich the oxygen in the nutrient solution; dissolving ozone in the nutrient solution by the aid of the micro-nano bubble generation technology to form micro-nano bubble ozone water and jointly sterilizing the nutrient solution by an ultraviolet sterilizer. The oxygen enriching and sterilizing device and the oxygen enriching and sterilizing method have the advantages that the dissolved oxygen in the nutrient solution can be effectively increased, root rotting phenomena of hydroponics plants can be reduced, and the yield can be increased; spreading of microbial diseases in the nutrient solution can be effectively suppressed, and the application amount of pesticides can be reduced.

The invention discloses fragrant grass vagina cleaning liquid and a preparation process thereof, and relates to the fragrant grass vagina cleaning liquid for preventing and treating gynecological inflammation and the preparation process thereof. The fragrant grass vagina cleaning liquid is prepared by processing glossy privet fruit, angelica dahurica, Chinese ligusticum rhizome, mint, divaricate saposhnikovia root, ash bark, amur corktree bark, yerbadetajo herba ecliptae, baical skullcap root, gardenia, lightyellow sophora root, motherwort herb, white paeony root, heartleaf houttuynia herb, nutgrass galingale rhizome, common cnidium fruit, rhubarb, spreading hedyotis herb, honeysuckle flower, dandelion, weeping forsythiae, belvedere fruit, borneol, borax, alum, citric acid, royal jelly, sorbic acid, sodium bicarbonate, glycerol, ethyl cellulose, vitamin C, sodium salt, citric acid and sodium hydroxide serving as raw materials. A product does not have stimulus or dependency, is not influenced by much secretion, and can kill bacteria and microorganism pathogen in vagina, protect mucosal tissues in the vagina, improve the physiological function of female genital organs and prevent and treat diseases.

A long-acting compound biologic organic-inorganic fertilizer is prepared from useful microbial bacteria (EV preparation), long-acting agent, organic substance, N, P, K, Zn, B, Mn, Mo, Fe, S, Ca and zeolite powder through proportionally mixing, stirring, and granulating. Its advantages are long acting time (160 days), high utilization rate increased by 25%, and high yield of agricultural crops.

The invention discloses a microbial-disease relation prediction method based on the similarity and the double random walk. According to the method, firstly, the disease function similarity is constructed by utilizing the disease gene relation and the gene function similarity information. Secondly, the disease Gaussian kernel similarity is constructed according to the known microbial disease relation. On the basis of the disease function similarity and the Gaussian kernel similarity, a final similarity of diseases is integrated. The similarity of microorganisms is derived from the Gaussian kernel similarity of the known microbial disease relation. The microorganism similarity information, the disease similarity information and the known microbial disease relation information are integratedinto a double-layer heterogeneous network. In this way, the microbial disease relation prediction is carried out in the heterogeneous network by utilizing the double-random walk method. According to the method, the relation between microbial diseases can be predicted. The method provides a foundation basis for biological experiments. By adopting the method, the manpower and the material cost are saved.

The present invention relates to disinfection of water polluted by microbial pathogens through the use of photosensitizers. The photosensitizer is a porphyrinoid which is part of an adduct comprising a resin, a spacer and said porphyrinoid. An apparatus wherein said adduct is excited by light sources and water is disinfected while flowing inside the apparatus is also provided. A system for the disinfection of water comprising said apparatus and further elements is also within the scope of the invention.

The present invention relates to a new strain of coronavirus and its application. Said invention utilizes the throat-swabbed cell colture of SARS patient to separate out a new type coronavirus, called by name of SARS coronavirus Fudan I strain. By infecting Vero E 6 cell and patient's serum the indirect FA display is positive, after the influenza virus A and B, RS virus and pathogens of pneumococcus, etc. are excluded, the tests show that said separated coronavirus is a variant strain of new coronavirus. Said strain can be used for providing basis for preparing SARS diagnosis reagent and researchnig and producing medicine for resisting and curing SARS disease.

The present invention concerns a method for identifying biologically active structures which are coded by the genome of microbial pathogens, using genomic pathogen nucleic acids.

The present invention discloses the use of a protease inhibitor in the preparation of a medicament for the treatment of microbial infections. The invention further discloses the use of a compound binding to a cross-β structure or an antibody specific for a cross-β structure in the preparation of a medicament for the treatment of microbial infections. The invention further discloses methods for attenuating microbial pathogens by deleting at least part of a gene encoding a cross-β structure forming protein. The invention also discloses an antimicrobial composition, and a kit for detecting microbial contamination in a solution or a substance.

The invention discloses a broad-spectrum composite microbial fungicide and a preparation method thereof. Original composite conidial powder consists of the following three microorganisms: bacillusthuringiensis GSICC32807, bacillus amyloliquefaciens GSICC32826 and pythiumoligandrum GSICC61615. Two types of bacterial spore powder and a type of fungal spore powder are mixed according to the weight ratio of 1:1:1 to prepare a broad-spectrum composite microbial fungicide product. The broad-spectrum composite microbial fungicide product provided by the invention can be quickly planted around the root of a plant to obviously prevent, resist and kill microbial diseases of various crops by competing infection sites with pathogenic bacteria, implementing the hyperparasitism action, secreting auxin, promoting nutrient absorption of the plant and the like; furthermore, the road-spectrum composite microbial fungicide has the effects of promoting the growth of the crops, increasing the yield and improving the quality.

A novel predator bacterium Burkholderia casidae is disclosed. The invention is directed to the isolation and use of Burkholderia casidae to control microbial diseases of plants. The genetic, biochemical and physiological characteristics of Burkholderia casidae are described. Biocontrol compositions comprising Burkholderia casidae, and antimicrobial compounds and antimicrobial preparations prepared from Burkholderia casidae are also disclosed, as are methods for accomplishing all of the foregoing.

The invention mainly relates to the mass spectrometric identification of pathogens in blood cultures from blood-stream infections (septicemia). The invention provides a method with which microbial pathogens can be separated in purified form from blood after a relatively brief cultivation in a blood culture flask, without any interfering human proteins or any residual fractions of blood particles such as erythrocytes and leukocytes, and can be directly identified by mass spectrometric measurement of their protein profiles. The method is based on the use of relatively strong tensides to destroy the blood particles by dissolving the weak cell membranes and most of the internal structures of the blood particles; in spite of the fact that tensides are regarded as strong ionization inhibitors in MALDI and other ionization processes required for mass spectrometric measurements. This method allows unknown pathogens to be obtained in their pure form by centrifuging or filtration and to be identified on the taxonomic level of species or subspecies. Problems with DNA from high levels of leukocytes can be resolved by special measures. After sufficient cultivation, the identification in a mass spectrometric laboratory takes only half an hour.

The invention relates to a method of reducing the incidence or severity of a disease or condition in a subject, said disease or condition being one associated with the presence of a microbial pathogen in an oral tissue of a subject, and including the use of a composition forming an anti-microbial and an immunogen against a microbial pathogen.

A portable pathogen analysis system (PPAS) designed to detect microbial pathogens at the point-of-sample collection. The system comprises a concentration tube used for the concentration of microbes in large volumes of water samples using super absorbent polymer (SAP) beads and a hand-powered centrifuge; and a processing component, which functions as a portable lab-on-a-disc droplet digital nucleic acid amplification system, which integrates DNA extraction, nucleic acid amplification, and post-amplicon analysis in a single unit. The present invention provides a fast, cost-effective, and user-friendly solution for microbial water quality analysis in low-resource settings.

The present invention relates generally to the field of detection of microorganisms, in particular detection of bacteria, to methods for measuring enzyme activity, such as DNA polymerase activity, and particularly relates to such methods performed on microbial crude lysates, useful for determining microbial enzyme activities which can be linked to amplification signal generators such as real-time Polymerase Chain Reaction (PCR) techniques, thereby enabling determination of microbial pathogens in samples such as unpurified blood and other body fluids. This invention also relates to reagents for use in such methods, and to test kits comprising such reagents for carrying out the methods.

The invention provides a composite microbial disease / insect-resistant agent for green vegetables and a manufacturing method thereof. The composite microbial disease / insect-resistant agent for green vegetables comprises a composite microbial inoculant and a fertilizer, wherein the composite microbial inoculant is a mixed microbial inoculant formed by fermenting Bacillus and Rhodospirillum in a culture medium; the fertilizer comprises a potassium fertilizer and a pH regulator; the mass ratio of the composite microbial inoculant to the fertilizer is (30-50):(50-70); and the mass ratio of the Rhodospirillum microbial inoculant to the Bacillus microbial inoculant is (1-3):1. By adopting the composite microbial inoculant, the agent has the advantages of sufficient nutrients and reasonable supply, can enhance the nutrient absorption capacity of the plant root, and effectively inhibits harmful bacteria from growth and reproduction. When being used for a long time, the agent can improve the soil and avoid multiple diseases and insects due to deficiency of nutrient elements.